ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,469.30
      0.39%
      US Tech 100
      19,181.60
      1.18%
      Dow Jones
      39,112.16
      -0.76%
      Brent Oil
      84.185
      -1.27%
      Bitcoin
      61,734.74
      2.44%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Oric Pharmaceuticals Inc (ORIC) Quote

      Oric Pharmaceuticals Inc

      Oric Pharmaceuticals Inc (ORIC)

      6.74
      -0.41
      (-5.73%)
      At close: June 25 4:00PM
      Delayed by 15 minutes
      6.74
      0.01
      ( 0.15% )
      After Hours: 7:17PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      6.74
      Bid
      6.75
      Ask
      7.21
      Volume
      379,186
      6.63 Day's Range 7.13
      5.27 52 Week Range 16.65
      Market Cap
      453.752M
      Previous Close
      7.15
      Open
      7.12
      Last Trade
      4
      @
      7.07
      Last Trade Time
      18:26:07
      Financial Volume
      $ 2,606,796
      VWAP
      6.8747
      Average Volume (3m)
      441,997
      Shares Outstanding
      67,422,307
      Dividend Yield
      -
      PE Ratio
      -4.51
      Earnings Per Share (EPS)
      -1.49
      Revenue
      -
      Net Profit
      -100.7M

      About Oric Pharmaceuticals Inc

      ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company h... ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.oricpharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Oric Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ORIC. The last closing price for Oric Pharmaceuticals was $7.15. Over the last year, Oric Pharmaceuticals shares have traded in a share price range of $ 5.27 to $ 16.65.

      Oric Pharmaceuticals currently has 67,422,307 shares outstanding. The market capitalization of Oric Pharmaceuticals is $453.75 million. Oric Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.51.

      ORIC Latest News

      More News

      Form 8-K - Current report

      June 14 2024
      Edgar (US Regulatory)

      ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

      June 07 2024
      GlobeNewswire Inc.

      ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

      May 29 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 06 2024
      Edgar (US Regulatory)

      ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates

      Initiated three ORIC-114 Phase 1b expansion cohorts in NSCLC patients with EGFR exon 20 insertion, HER2 exon 20 insertion, or EGFR atypical mutations; updated Phase 1b data expected in the first...

      May 06 2024
      GlobeNewswire Inc.

      ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...

      May 03 2024
      GlobeNewswire Inc.

      ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC

      Initiated multiple Phase 1b expansion cohorts to determine the RP2D of ORIC-114 in NSCLC patients with EGFR exon 20, HER2 exon 20, or EGFR atypical mutations Additionally, the company initiated an...

      April 15 2024
      GlobeNewswire Inc.

      ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting

      ORIC-944, a potent and selective allosteric PRC2 inhibitor, demonstrates superior preclinical drug properties and longer clinical half-life which supports a potential best-in-class profile versus...

      April 08 2024
      GlobeNewswire Inc.

      ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

      April 05 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.69-9.28667563937.437.686.634779147.16474603CS
      4-1.89-21.90034762468.639.3656.634340458.15721329CS
      12-5.78-46.166134185312.5212.86.634419979.0693498CS
      26-2.24-24.94432071278.9816.656.6349738310.95750231CS
      52-0.55-7.544581618667.2916.655.274525449.374729CS
      156-11.67-63.389462248818.4126.72.364033538.07342965CS
      260-19.26-74.07692307692640.812.3635312111.85449671CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RIVNRivian Automotive Inc
      $ 17.73
      (48.24%)
      		56.65M
      CHNRChina Natural Resources Inc
      $ 1.06
      (35.90%)
      		3.83M
      WTOUTime Limited
      $ 0.78
      (19.05%)
      		31.02k
      GRDIGRIID Infrastructure Inc
      $ 2.35
      (18.69%)
      		828.79k
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.312
      (17.74%)
      		19.04M
      ALLKAllakos Inc
      $ 1.04
      (-11.86%)
      		161.44k
      SPECSpectaire Holdings Inc
      $ 0.53
      (-11.67%)
      		1.54M
      TSHATaysha Gene Therapies Inc
      $ 2.21
      (-10.34%)
      		102.52k
      GLYCGlycoMimetics Inc
      $ 0.3025
      (-9.43%)
      		1.98M
      TCONTRACON Pharmaceuticals Inc
      $ 1.35
      (-9.40%)
      		2.32k
      RIVNRivian Automotive Inc
      $ 17.73
      (48.24%)
      		56.65M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.312
      (17.74%)
      		19.04M
      NVDANVIDIA Corporation
      $ 127.66
      (1.25%)
      		10.54M
      LCIDLucid Group Inc
      $ 2.76
      (10.40%)
      		6.39M
      SIRISirius XM Holdings Inc
      $ 2.69
      (1.13%)
      		4.71M

      ORIC Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      ORIC 10Q due 5/6
      👍️0
      Monksdream Monksdream 2 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 4 months ago
      ORIC 10Q due 3/16
      👍️0
      Monksdream Monksdream 4 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 4 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 4 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 5 months ago
      ORIC new 52 weewk high
      👍️0
      Monksdream Monksdream 5 months ago
      ORIC new 52 week high
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      $ORIC LOOKS LIKE $6 COMING
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: Tapped $5.40....... still got steam

      It ain't over yet





      GO $ORIC
      👍️0
      DH112 DH112 2 years ago
      Today is green fields
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

      https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: 5.25 now........................... lets get to $10

      I know you can do it babyyyyyyyyyyyyyyyyy


      GO $ORIC
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC : Now at 4.90

      YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

      Me likes it


      GO $ORIC
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

      The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

      The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

      The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


      Write to Dean Seal at dean.seal@wsj.com


      (END) Dow Jones Newswires

      December 22, 2022 07:25 ET (12:25 GMT)
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

      Letssssssss goooooooooooooooooo.


      Added 5k shares here at 4.30

      Great NEWS


      https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

      GO $ORIC
      👍️0

      Your Recent History

      NASDAQ
      ORIC
      Oric Pharmaceuticals
      BIT
      P209G9
      NLBNPIT209G9 20991231 83...
      USOTC
      FDOCD
      Charging Robotics (PK)
      NASDAQI
      TRESTATTEUR
      Strategic Technology & E...
      Delayed Upgrade Clock